Seeking Alpha

Advaxis jumps after FDA grants orphan drug designation for ADXS-HPV

  • Advaxis (ADXS +5.7%) shares jump after the FDA grants the company an orphan drug designation for its leading drug candidate, ADXS-HPV, which aims to treat HPV-caused head/neck cancer.
Comments (3)
  • Fact Man
    , contributor
    Comments (16) | Send Message
    Awesome news! This company has a bright future.
    4 Nov 2013, 12:22 PM Reply Like
  • johnnyv77
    , contributor
    Comments (4) | Send Message
    Is there a price target?
    5 Nov 2013, 04:38 AM Reply Like
  • rooksmith
    , contributor
    Comments (87) | Send Message
    What happened to it today (11/11)?
    11 Nov 2013, 02:46 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: